DECEMBER, 2013 Gene-Related Patents Issued - Full patent: http://patft.uspto.gov/netahtml/PTO/srchnum.htm | ||||
CHEMISTRY: MOLECULAR BIOLOGY AND MICROBIOLOGY | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,603,795 | Fungal protease and use thereof | AB Enzymes Oy | 10-Dec-13 | Finland |
8,609,390 | Fungal serine protease and use thereof | AB Enzymes Oy | 17-Dec-13 | Finland |
8,614,085 | Yeast with increased butanol tolerance involving a multidrug efflux pump gene | Butamax(TM) Advanced Biofuels LLC | 24-Dec-13 | United States |
8,603,996 | Modular aptamer-regulated ribozymes | California Institute of Technology | 10-Dec-13 | United States |
8,609,335 | Self-assembled single molecule arrays and uses thereof | Callida Genomics, Inc. | 17-Dec-13 | United States |
8,614,058 | Molecular prognostic signature for predicting breast cancer metastasis, and uses thereof | Celera Corporation | 24-Dec-13 | United States |
8,597,910 | DNA encoding Von Willebrand Factor (VWF) and methods and cells for producing VFW, and VFW produced by the DNA, methods and cells | Children's Medical Center Corporation | 3-Dec-13 | United States |
8,609,396 | Microorganism producing O-acetyl-homoserine and the method of producing O-acetyl-homoserine using the microorganism | CJ Cheiljedang Corporation | 17-Dec-13 | Korea |
8,603,797 | Methods and compositions for targeted mutagenesis in bacteria | Cornell University | 10-Dec-13 | United States |
8,609,369 | Yarrowia peroxisomal 2,4-dienoyl-CoA reductase promoter regions for gene expression in yeast | E I du Pont de Nemours and Company | 17-Dec-13 | United States |
8,609,405 | GABA neuron progenitor cell marker 65B13 | Eisai R&D Management Co., Ltd. | 17-Dec-13 | Japan |
8,597,918 | Process of separating components of a fermentation broth | Genomatica, Inc. | 3-Dec-13 | United States |
8,609,394 | Biotechnological production of chondroitin | Gnosis S.p.A. | 17-Dec-13 | Italy |
8,597,942 | System for expression of genes in plants | iBio, Inc. | 3-Dec-13 | United States |
8,617,845 | Sequence diversity generation in immunoglobulins | Innovative Targeting Solutions, Inc. | 31-Dec-13 | Canada |
8,597,931 | Mutant yeast strains capable of accumulating a large quantity of lipids | Institut National de la Recherche Agronomique | 3-Dec-13 | France |
8,603,798 | Process for large scale production of plasmid DNA by E. coli fermentation | Merck Sharp & Dohme Corp. | 10-Dec-13 | United States |
8,617,875 | Expression vector suitable for expression of a coding sequence for gene therapy | Mogam Biotechnology Research Institute | 31-Dec-13 | Korea |
8,603,774 | Extract of E. coli cells having mutation in ribosomal protein S12, and method for producing protein in cell-free system using the extract | National Food Research Institute | 10-Dec-13 | Japan |
8,609,342 | Reporter gene assay method | Otsuka Pharmaceutical Co., Ltd. | 17-Dec-13 | Japan |
8,603,824 | Process for improved protein expression by strain engineering | Pfenex, Inc. | 10-Dec-13 | United States |
8,603,814 | Method of inhibiting nonsense-mediated mRNA decay | Rutgers the State University of New Jersey | 10-Dec-13 | United States |
8,597,877 | Polymorphic loci that differentiate Escherichia coli O157:H7 from other strains | Seattle Children's Hospital | 3-Dec-13 | United States |
8,597,923 | Oxidation of compounds using genetically modified Candida | SyntheZyme, LLC | 3-Dec-13 | United States |
8,597,880 | Methods and compositions for identifying increased risk of developing fragile X-associated disorders | The Fred Hutchinson Cancer Research Center | 3-Dec-13 | United States |
8,617,876 | Rhodopsin gene conserved regions in a viral vector enhance expression | The Provost Fellows and Scholars of the College of the Holy and Undivided Trinity of Queen Elizabeth | 31-Dec-13 | Ireland |
8,614,094 | Compositions and methods for determining genetic polymorphisms in the TMEM216 gene | The Regents of the University of California | 24-Dec-13 | United States |
8,617,815 | Molecules with effects on cellular development and function | The Regents of the University of California | 31-Dec-13 | United States |
8,617,813 | Methods for modulating embryonic stem cell differentiation | The United States of America as represented by the Secretary of the Department of Health and Human Services | 31-Dec-13 | United States |
8,617,812 | Polymorphism in bovine prion protein gene sequence | The United States of America, as represented by the Secretary of Agriculture | 31-Dec-13 | United States |
8,603,748 | Genetic methods for speciating Campylobacter | The United States of America, as represented by the Secretary of Agriculture | 10-Dec-13 | United States |
8,597,883 | Biomarkers for cancer-related fatigue and use thereof | The United States of America, as represented by the Secretary, Department of Health and Human Services | 3-Dec-13 | United States |
8,597,885 | Accelerated progression relapse test | University of Notre Dame | 3-Dec-13 | United States |
8,614,060 | Methods and compositions for predicting drug responses | University of Washington | 24-Dec-13 | United States |
8,597,893 | Human phospholipase A2 epsilon | Washington University In St. Louis | 3-Dec-13 | United States |
COMBINATORIAL CHEMISTRY TECHNOLOGY | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,598,080 | Rice cultivar designated `CL131` | Board of Supervisors of Louisiana State University And Agricultural and Mechanical College | 3-Dec-13 | United States |
DRUG | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,598,136 | Baculovirus-mediated transgene expression in both mammalian and insect cells | Academia Sinica | 3-Dec-13 | Taiwan |
8,598,139 | Lipid formulated dsRNA targeting the PCSK9 gene | Alnylam Pharmaceuticals, Inc. | 3-Dec-13 | United States |
RE44,681 | Compositions and methods for inhibiting growth of SMAD4-deficient cancers | Biogen Idec MA Inc. | 31-Dec-13 | United States |
8,609,626 | NLK as a marker for diagnosis of liver cancer and as a therapeutic agent thereof | Catholic University Industry Academic Cooperation Foundation | 17-Dec-13 | Korea |
8,603,997 | siRNA that inhibits WT1 gene expression and uses thereof | Haruo Sugiyama | 10-Dec-13 | Japan |
8,603,480 | Human cytomegalovirus neutralizing antibodies and use thereof | Institute for Research in Biomedicine | 10-Dec-13 | United States |
8,598,188 | Method for predicting therapeutic efficacy of chemotherapy on non-small-cell lung cancer | Kinki University | 3-Dec-13 | United States |
8,609,065 | Molecules for targeting compounds to various selected organs, tissues or tumor cells | Kuik-Romeijn; Petra Van | 17-Dec-13 | Netherlands |
8,618,070 | Anti-sense oligonucleotides targeted against exon 9 of IL-23R.alpha. gene and method of using same to induce exon skipping and to treat inflammatory bowel diseases | Medical Diagnostic Laboratories, LLC | 31-Dec-13 | United States |
8,603,465 | Methods for treatment of polyposis | Merck Sharp & Dohme, Corp. | 10-Dec-13 | United States |
8,603,995 | dsRNA for treating viral infection | Novartis AG | 10-Dec-13 | Switzerland |
8,598,133 | Methods for treating pain | The Regents of the University of Colorado | 3-Dec-13 | United States |
8,609,108 | Gamma-glutamyl transpeptidase attenuated Francisella | The Secretary of State for Defence | 17-Dec-13 | United Kingdom |
8,603,459 | Simian adenovirus nucleic acid and amino acid sequences, vectors containing same, and methods of use | The Trustees of the University of Pennsylvania | 10-Dec-13 | United States |
8,598,143 | Sequence-specific inhibition of small RNA function | University of Massachusetts | 3-Dec-13 | United States |
8,603,994 | Transcriptional repression leading to Parkinson's disease | Valted, LLC | 10-Dec-13 | United States |
8,597,637 | Breast cancer therapy using an engineered respiratory syncytial virus | Zhang; Weidong | 3-Dec-13 | United States |
MULTICELLULAR LIVING ORGANISMS | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,598,412 | Seed specific USP promoters for expressing genes in plants | Dow AgroSciecnes, LLC. | 3-Dec-13 | United States |
8,598,413 | AAD-1 event DAS-40278-9, related transgenic corn lines, event-specific identification thereof, and methods of weed control involving AAD-1 | Dow AgroSciecnes, LLC. | 3-Dec-13 | United States |
8,598,409 | Non-human organism comprising a gene expression modulation system encoding a chimeric retinoid X receptor | Intrexon Corporation | 3-Dec-13 | United States |
8,604,275 | Constitutive translationally controlled tumor protein (TCTP) promoter from oil palm type 2 | Malaysian Palm Oil Board | 10-Dec-13 | Malaysia |
8,614,370 | Nucleic acid sequences from Diabrotica virgifera virgifera leconte and uses thereof | Monsanto Technology LLC | 24-Dec-13 | United States |
8,609,934 | In vivo assembly of transcription units | Monsanto Technology LLC | 17-Dec-13 | United States |
8,604,276 | Switchgrass ubiquitin promoter (PVUBI2) and uses thereof | University of Tennessee Research Foundation | 10-Dec-13 | United States |
8,609,928 | Squash leaf curl virus (SLCV) resistance in cucurbits | Vilmorin & Cie | 17-Dec-13 | France |
NATURAL RESINS OR DERIVATIVES | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,604,169 | Nucleic acids and corresponding proteins entitled 251P5G2 useful in treatment and detection of cancer | Agensys, Inc. | 10-Dec-13 | United States |
8,609,819 | Extracellular serine protease | Board of Trutees of the University of Arkansas | 17-Dec-13 | United States |
8,604,173 | Dopaminergic neuron progenitor cell marker 187A5 | Eisai R&D Management Co., Ltd. | 10-Dec-13 | Japan |
ORGANIC COMPOUNDS | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,598,333 | SiRNA silencing of genes expressed in cancer | Alnylam Pharmaceuticals, Inc. | 3-Dec-13 | United States |
8,604,176 | Protein-responsive RNA control devices and uses thereof | California Institute of Technology | 10-Dec-13 | United States |
8,598,330 | CC2D2A gene mutations associated with joubert syndrome and diagnostic methods for identifying the same | Centre for Addiction and Mental Health | 3-Dec-13 | Canada |
8,604,183 | Compositions comprising alternating 2'-modified nucleosides for use in gene modulation | Isis Pharmaceuticals, Inc. | 10-Dec-13 | United States |
8,618,273 | Partial fragment of REIC/Dkk-3 gene and cancer therapeutic agent comprising the same | Kumon; Hiromi | 31-Dec-13 | Japan |
8,609,830 | Methods and compositions for RNA interference | Merck Sharp & Dohme Corp. | 17-Dec-13 | United States |
8,618,277 | RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) | Merck Sharp & Dohme Corp. | 31-Dec-13 | United States |
8,598,328 | Tol1 factor transposase and DNA introduction system using the same | National University Corporation Nagoya University | 3-Dec-13 | Japan |
8,604,180 | DNA fragment having promoter function | Research Institute of Innovative Technology for the Earth | 10-Dec-13 | Japan |
ORGANIC COMPOUNDS | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,618,304 | Acylamino-substituted cyclic carboxylic acid derivatives and their use as pharmaceuticals | Sanofi | 31-Dec-13 | France |
8,614,305 | Nonviral gene delivery vector iopamidol, protamine, ethiodized oil reagent (VIPER) | The Board of Trustees of the Leland Stanford Junior University | 24-Dec-13 | United States |
8,604,179 | Nucleic acid comprising chimeric gene derived from hepatitis C virus | Toray Industries, Inc. | 10-Dec-13 | Japan |
8,609,831 | RNA-mediated gene modulation | University of Southern California | 17-Dec-13 | United States |
PLANT PROTECTING AND REGULATING COMPOSITIONS | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,597,913 | Method of constructing an expression cassette comprising regulatory sequences of a target gene of a plant for expressing gene products | Syngenta Participations AG | 3-Dec-13 | Switzerland |
SURGERY | ||||
Pat No | Title | Assignee | Date Issued | Country |
8,620,423 | Methods for thermal modulation of nerves contributing to renal function | Medtronic Ardian Luxembourg S.a.r.l. | 31-Dec-13 | Luxembourg |
Login
Advertisements
Eden's Bounty Multi-SanTM
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
Colorless, odorless, biodegradable instant sanitizer is effective against both gram positive and gram-negative bacteria; kills in 30 seconds. Free of chlorine and quaternary ammonium compounds. EPA registered food contact surface sanitizer. Austin Davis Industries, Inc.
TERRA+ CLEAN Acid-Replacement Surface Cleaner
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.
Safe, totally natural, 100% biodegradable, multi-functional cleaning product providing safety in the workplace for both humans and environmental surfaces - without compromising performance. Can be diluted up to 25:1. Austin Davis Industries, Inc.